Nicholas Vita Net Worth: Estimate, Sources, and How It’s Calculated

Nicholas Vita is best known as the founding CEO of Columbia Care, one of the largest multi-state medical cannabis operators in the United States. Based on his confirmed equity stake of roughly 36.9 million shares in Columbia Care (documented in SEC EDGAR filings), combined with his executive compensation package and the company's market performance over his tenure, a reasonable net worth estimate for Nicholas Vita falls in the range of $20 million to $60 million as of mid-2026. That's a wide band, and below I'll explain exactly why, and what would tighten it. If you're searching for the Nicholas Vita net worth figure, the exact number depends heavily on how his Columbia Care share sales played out during the 2020 to 2021 cannabis boom and the later downturn Nicholas Vita net worth estimate.

Which Nicholas Vita are we talking about?

Before diving into numbers, it's worth confirming the right person. The Nicholas Vita most likely to surface in a net worth search is Nicholas Vita, co-founder and longtime Chief Executive Officer of Columbia Care, LLC, a licensed medical cannabis company headquartered in New York. If you are specifically looking for Nicholas Van Varenberg net worth, confirm the person’s identity and the source of the reported figures before comparing estimates net worth search. He was named CEO Monthly Magazine's "CEO of the Year" in 2018 and was identified by PR Newswire in 2019 as the company's chief executive in conjunction with Columbia Care's selection by the Virginia Board of Pharmacy. There is no widely known entertainer, athlete, or politician named Nicholas Vita who competes for this search. If you landed here looking for a different Nicholas or Nicolas (the site covers a wide range, from Nicolas Cage to Nicolas Puech), you're on the wrong page, but for the cannabis executive, you're in the right place.

What net worth actually means, and why the number varies

Net worth is simply assets minus liabilities. For a private individual or an executive whose wealth is tied up in company equity, that calculation gets complicated fast. The main reasons estimates differ across websites come down to three things: the share price used on the calculation date, whether unvested or restricted stock is included, and whether the analyst has access to private assets (real estate, investments, debt) that never appear in public filings. For someone like Nicholas Vita, whose primary documented wealth signal is a large equity stake in a cannabis company that traded on public markets under volatile conditions, the range between a pessimistic and optimistic estimate can easily be 2x to 3x.

How we built this estimate, sources and methodology

The anchor for any estimate of Nicholas Vita's net worth is SEC EDGAR. An SEC filing lists him as "Chief Executive Officer and Director" with 36,899,860 shares reported in the ownership table. That's the hardest number we have. From there, the methodology works like this: take the share count, apply Columbia Care's trading price at meaningful dates (peak, average, and recent), and subtract a standard liquidity discount for insider-held shares (typically 10 to 30 percent) because insiders can't sell everything at once without depressing the price. Beyond equity, the April 26, 2019 employment agreement between Columbia Care LLC and Nicholas Vita (hosted on Justia) provides evidence of a formal executive compensation structure, though the specific salary and bonus figures in that agreement are not fully public. No property records, trust filings, or investment disclosures for Vita are in the public domain that would add precision to the private-asset side of the ledger.

Career and business signals that shape the number

Nicholas Vita co-founded Columbia Care and led it from a small medical cannabis startup to one of the country's largest multi-state operators. That founding status matters enormously for net worth, founders typically hold equity at a far lower cost basis than market investors, meaning even a modest share price produces significant paper wealth. His tenure as CEO spanned roughly a decade before he retired from the role effective January 15, 2024, then stepped down from the Board entirely on June 25, 2024, per a 10-K/A SEC filing. During Columbia Care's public market years, the company's stock reached peaks well above $1 per share (on Canadian exchanges and OTC markets in the US) before the broader cannabis sector downturn compressed valuations industry-wide. Vita also held the title of Director throughout most of his time with the company, which typically comes with additional stock grants.

The cannabis sector context is important here. Multi-state operators (MSOs) like Columbia Care experienced dramatic swings in valuation between 2018 and 2024. At the sector's peak around 2021, Vita's equity stake at elevated share prices would have implied a paper net worth at the higher end of our range or beyond it. By the time he retired in early 2024, the sector had retreated significantly, compressing that number. Executive compensation at MSOs of Columbia Care's scale typically runs in the $500,000 to $2 million annual base salary range for a CEO, with performance bonuses and equity grants on top, so accumulated cash compensation over a decade-long tenure is also a meaningful contributor to total wealth.

Assets vs. liabilities: what public records can and can't confirm

On the confirmed side: the SEC ownership table gives us the share count, and the employment agreement confirms that a formal compensation structure existed. These are documented facts. Everything else involves inference. We don't have public records confirming real estate holdings, investment accounts, or personal debt for Nicholas Vita. We also don't know what he did with Columbia Care shares over time, insiders often sell periodically through 10b5-1 plans, which would convert paper equity into liquid cash (and potentially reduce the remaining share count). Without Form 4 insider transaction filings being clearly attributable in the public record at this time, it's not possible to confirm exactly how many shares he retained at retirement versus how many he sold during his tenure.

The net worth estimate range and how confident we are

Putting it all together, the most defensible estimate for Nicholas Vita's net worth as of June 2026 is $20 million to $60 million, with a midpoint around $35 million. Confidence level: moderate. If you are also looking into Nicolas Vansteenberghe net worth, you should compare how each executive's wealth is tied to public versus private holdings. The lower bound reflects a scenario where Columbia Care's share price remained depressed, Vita had sold relatively few shares at higher prices, and personal liabilities offset some of the accumulated compensation. The upper bound reflects a scenario where he liquidated meaningful equity during the 2020 to 2021 sector peak, retained diversified assets, and collected a decade of executive-level compensation largely intact. For comparison, other business executives in adjacent silos on this site, such as Nicholas Zoullas, a shipping executive, or Nicholas Vansteenberghe in European business circles, show how dramatically net worth ranges vary depending on sector volatility and the proportion of wealth held in publicly traded equity versus private assets. If you are also looking up Nicholas Zoullas net worth, his shipping-industry background and asset mix are typically used to explain how his figure is estimated. Cannabis is among the more volatile sectors, which is the primary reason the confidence band here is wider than it would be for, say, a real estate developer with deeded property in public county records. If you are specifically searching for Nicholas Zamiska net worth, the most reliable approach is to confirm the exact individual and then follow the same SEC-backed methodology described here.

How to verify and update this estimate yourself

If you want to check the current state of the estimate or update it with newer data, here's the practical path to follow.

1. Search SEC EDGAR (sec.gov/cgi-bin/browse-edgar) for "Nicholas Vita" as an individual filer. Look for Form 4 filings, which record every buy and sell transaction by insiders. These will tell you whether he sold shares during the sector peak and how many he retained at retirement.
2. Check Columbia Care's most recent proxy statement (DEF 14A) for historical compensation tables. These documents, also on EDGAR under the company name, disclose named executive officer salaries, bonuses, and equity grants by year.
3. Look up the Columbia Care stock price history on any financial data site (Yahoo Finance, Google Finance, or Bloomberg) to understand what share prices were at key dates — IPO, sector peak, and Vita's retirement date in January 2024. Apply those prices to the share count to see the equity value at each point.
4. Search county property records in New York (the company's HQ state) and any other state where Vita is known to have resided. These are publicly searchable and would add or subtract from the total picture significantly.
5. Monitor business news sources like MJBizDaily (cannabis industry), Bloomberg, and Reuters for any post-retirement announcements — a new venture, board seat with compensation, or investment fund involvement would materially change the estimate.

The single biggest update that would change this estimate is a complete Form 4 transaction history showing insider share sales. If those records confirm that Vita sold a substantial portion of his 36.9 million shares during 2020 to 2021 (when cannabis stocks traded at multiples of their later values), the net worth figure would shift meaningfully upward. If the records show he held most shares through the downturn, the lower end of the range becomes more relevant. That's the crux of the uncertainty here, and it's the one data point most worth tracking down.